Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AVENANCE - A Non-interventional Study to Provide Real-world Data on the Use of Avelumab as a Maintenance Treatment for Patients With Advanced or Metastatic Urothelial Carcinoma

NCT04822350 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04822350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04822350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AVENANCE - A Non-interventional Study to Provide Real-world Data on the Use of Avelumab as a Maintenance Treatment for Patients With Advanced or Metastatic Urothelial Carcinoma
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 13, 2021
Completion date
April 25, 2024
Enrollment
596 (actual)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

urothelial carcinoma